Neurocrine Biosciences
NBIX
NBIX
198 hedge funds and large institutions have $3.98B invested in Neurocrine Biosciences in 2015 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 87 increasing their positions, 52 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 174 → 198 (+24)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
198
Holding in Top 10
4
Calls
$61.7M
Puts
$18.9M
Top Buyers
| 1 | +$67.8M | |
| 2 | +$20.1M | |
| 3 | +$19M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$16.6M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$14.1M |
Top Sellers
| 1 | -$53.2M | |
| 2 | -$48.4M | |
| 3 | -$39.6M | |
| 4 |
O
OrbiMed
New York
|
-$35.3M |
| 5 |
PA
Perceptive Advisors
New York
|
-$21.8M |